Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
SURF Surface Oncology, Inc. monthly Stock Chart
SURF [NASD]
Surface Oncology, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.97 Insider Own2.50% Shs Outstand26.93M Perf Week8.38%
Market Cap48.74M Forward P/E- EPS next Y-1.62 Insider Trans0.75% Shs Float23.20M Perf Month-31.95%
Income-54.80M PEG- EPS next Q0.43 Inst Own62.10% Short Float0.39% Perf Quarter-14.22%
Sales15.40M P/S3.17 EPS this Y-495.10% Inst Trans-5.33% Short Ratio0.56 Perf Half Y20.67%
Book/sh2.03 P/B0.89 EPS next Y-60.60% ROA-36.80% Target Price10.33 Perf Year-61.08%
Cash/sh3.91 P/C0.46 EPS next 5Y- ROE-70.60% 52W Range1.15 - 5.09 Perf YTD-3.72%
Dividend- P/FCF- EPS past 5Y- ROI-88.70% 52W High-64.41% Beta-
Dividend %- Quick Ratio5.60 Sales past 5Y- Gross Margin- 52W Low57.39% ATR0.37
Employees49 Current Ratio5.60 Sales Q/Q-95.90% Oper. Margin- RSI (14)40.78 Volatility16.11% 15.65%
OptionableNo Debt/Eq0.09 EPS Q/Q-235.50% Profit Margin- Rel Volume0.27 Prev Close1.81
ShortableYes LT Debt/Eq0.09 EarningsMar 05 Payout- Avg Volume159.24K Price1.81
Recom1.70 SMA20-20.00% SMA50-34.82% SMA200-18.64% Volume43,237 Change0.00%
Sep-19-18Initiated Robert W. Baird Outperform
May-14-18Initiated Goldman Neutral $17
May-14-18Initiated Evercore ISI Outperform $26
Mar-17-20 08:00AM  Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617 GlobeNewswire
Mar-12-20 10:39AM  Earnings Beat: Surface Oncology, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts Simply Wall St. -6.33%
Mar-10-20 06:20AM  Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2019 GlobeNewswire +10.08%
Mar-06-20 11:30AM  Is Surface Oncology (SURF) Outperforming Other Medical Stocks This Year? Zacks -8.36%
Feb-25-20 04:05PM  Surface Oncology to Present at the 40th Annual Cowen Healthcare Conference GlobeNewswire -14.43%
Feb-19-20 11:30AM  Is Surface Oncology (SURF) Stock Outpacing Its Medical Peers This Year? Zacks +9.68%
Feb-04-20 06:58AM  Surface Oncology, Inc. (SURF) Shares March Higher, Can It Continue? Zacks
Jan-28-20 07:12AM  The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics Benzinga -8.62%
Jan-27-20 04:05PM  Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials GlobeNewswire -5.84%
Dec-23-19 10:24AM  Did Hedge Funds Drop The Ball On Surface Oncology, Inc. (SURF) ? Insider Monkey
Dec-09-19 05:45PM  Notice to Shareholders of Surface Oncology, Inc. (NASDAQ: SURF) Regarding Dismissal of Putative Investor Class Action Business Wire -6.70%
Nov-26-19 11:07AM  Company News For Nov 26, 2019 Zacks +10.87%
08:00AM  Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference GlobeNewswire
Nov-25-19 08:00AM  Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures GlobeNewswire -21.03%
Nov-18-19 06:30AM  Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day GlobeNewswire -11.67%
Nov-12-19 07:45AM  Surface Oncology, Inc. (SURF) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:30AM  Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019 GlobeNewswire
Nov-07-19 08:00AM  Surface Oncology Presents Updates at the Society for Immunotherapy of Cancers Annual Meeting GlobeNewswire
Oct-26-19 06:25PM  Kaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Investors - SURF ACCESSWIRE
Oct-07-19 07:00AM  Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City GlobeNewswire
Sep-23-19 12:50PM  Here's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely Simply Wall St.
Sep-18-19 05:55PM  IPO INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE -7.32%
Sep-17-19 05:25PM  Lifshitz & Miller LLP Announces Investigation of Curaleaf Holdings, Inc., Granite Construction, Inc., Karyopharm Therapeutics, Inc., ProPetro Holdings Corp., SAExploration, Inc., Sunnova Energy International, Inc., and Surface Oncology, Inc. PR Newswire -8.48%
Sep-03-19 04:05PM  Surface Oncology to Present at the Baird 2019 Global Healthcare Conference GlobeNewswire
01:45PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
07:00AM  Ramy Ibrahim, M.D. to Join Surface Oncology Board of Directors GlobeNewswire
Aug-28-19 10:45AM  ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire +5.56%
Aug-27-19 08:00AM  Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Sunnova Energy on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Aug-21-19 08:45PM  IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-20-19 01:15PM  URGENT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-15-19 11:20PM  ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-14-19 08:55PM  Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Aug-12-19 06:20PM  IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-08-19 09:05PM  URGENT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-07-19 10:30PM  IMPORTANT INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
09:30PM  Bragar Eagel & Squire, P.C. is Investigating Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
10:07AM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:05AM  Surface Oncology, Inc. (SURF) Reports Q2 Loss, Lags Revenue Estimates Zacks
06:05AM  Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2019 GlobeNewswire
Aug-06-19 05:52PM  Shareholder Alert: Robbins Arroyo LLP is Investigating Surface Oncology, Inc. (SURF) Business Wire
12:55PM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:30AM  Will Surface Oncology, Inc. (SURF) Report Negative Q2 Earnings? What You Should Know Zacks
Aug-03-19 11:05AM  Shareholder Rights Law Firm Johnson Fistel Launches Investigations PR Newswire
Aug-01-19 01:15PM  INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE +10.41%
Jul-30-19 09:25PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Jul-29-19 01:15PM  IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Jul-26-19 11:40PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jul-25-19 03:09PM  Investors Who Bought Surface Oncology (NASDAQ:SURF) Shares A Year Ago Are Now Down 79% Simply Wall St.
Jun-07-19 12:00PM  Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference GlobeNewswire
May-31-19 01:33PM  Analysts Recommend These 3 Falling Knives GuruFocus.com
May-24-19 06:00AM  Surface Oncology Presents Preclinical Data Further Supporting Anti-Tumor Mechanism of CD73 and CD39 Programs at Brisbane Immunotherapy 2019 GlobeNewswire
May-15-19 04:00PM  Surface Oncology to Present at Two Upcoming Healthcare Conferences GlobeNewswire
May-09-19 10:55AM  Surface Oncology, Inc. (SURF) Reports Q1 Loss, Tops Revenue Estimates Zacks -7.48%
07:00AM  Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2019 GlobeNewswire
Apr-24-19 07:00AM  Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day GlobeNewswire
Apr-01-19 07:00AM  Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer GlobeNewswire
Mar-04-19 07:00AM  Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference GlobeNewswire
Feb-21-19 09:01AM  Could Surface Oncology, Inc.s (NASDAQ:SURF) Investor Composition Influence The Stock Price? Simply Wall St. -8.93%
Feb-04-19 04:21PM  Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388 GlobeNewswire
Jan-16-19 04:50PM  Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins GlobeNewswire
Jan-10-19 06:00AM  Kill the Cancer Stem Cell, Kill the Cancer: How One Biotech is Hitting Cancer at the Cause ACCESSWIRE
Jan-04-19 07:00AM  Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board GlobeNewswire +13.00%
Dec-21-18 07:00AM  Surface Oncology Added to the NASDAQ Biotechnology Index GlobeNewswire -8.64%
Dec-18-18 04:01PM  Surface Oncology Resets Portfolio Priorities, Extends Cash Runway Through 2021 GlobeNewswire -5.24%
Dec-17-18 07:00AM  Surface Oncology Promotes Jessica Fees to Senior Vice President, Finance and Business Operations GlobeNewswire -5.21%
Nov-20-18 07:00AM  Surface Oncology Announces Upcoming Investor Presentations GlobeNewswire
Nov-13-18 06:30AM  Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018 GlobeNewswire
Sep-19-18 03:43PM  Surface Oncology Offers 'Robust Pipeline,' Baird Says In Bullish Initiation Benzinga +10.19%
Aug-30-18 09:59AM  Surface Oncology to Present at the Baird 2018 Global Healthcare Conference GlobeNewswire
Aug-14-18 07:00AM  Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018 GlobeNewswire
Jul-30-18 02:24PM  FDA Grants Orphan Drug Designation to Surface Oncologys SRF231 for the Treatment of Multiple Myeloma GlobeNewswire
Jul-03-18 06:23AM  Goodwin dominates this years record batch of Mass. biotech IPOs American City Business Journals
Jun-21-18 07:00AM  Surface Oncology Recognized as one of the Best Places to Work by Boston Business Journal GlobeNewswire
Jun-20-18 10:01PM  [$$] Eidos Therapeutics Goes Public, Joining Biotech IPO Flurry The Wall Street Journal
08:00AM  Kaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Stockholders ACCESSWIRE
Jun-18-18 03:31PM  Stocks Keep Paring Losses, But Dow Jones Still Lags As This Chipmaker Tumbles Investor's Business Daily +13.04%
Jun-12-18 07:00AM  Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF373 / NZV930 GlobeNewswire
Jun-11-18 05:07PM  Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index GlobeNewswire
Jun-08-18 07:10AM  Surface Oncology to Present at Goldman Sachs 39th Annual Global Healthcare Conference GlobeNewswire +8.04%
Jun-07-18 04:42PM  Who Owns Surface Oncology Inc (NASDAQ:SURF)? Simply Wall St.
May-29-18 05:00PM  Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018 GlobeNewswire -6.01%
May-21-18 07:25AM  Stock Performance Review on Tesaro and Three Other Biotech Industry ACCESSWIRE
May-15-18 04:01PM  Surface Oncology to Present at 2018 UBS Global Healthcare Conference GlobeNewswire
Apr-23-18 04:30PM  Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement GlobeNewswire -6.73%
Apr-18-18 09:00PM  Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement GlobeNewswire
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company develops human immunoglobulin isotype G4 monoclonal antibodies, including SRF231 inhibiting CD47; NZV930 inhibiting CD73; SRF617 inhibiting CD39; and SRF388 targeting interleukin 27. It also develops various earlier stage programs that targets other critical components of the tumor microenvironment, including regulatory T cells and natural killer cells. The company has a strategic collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies. Surface Oncology, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goater JeffChief Executive OfficerFeb 05Buy3.235,00016,150262,000Feb 07 04:05 PM
open in yahoo | open in reuters | open in google